Celex Oncology Innovations Limited (Companies House Registration Number 11085607) is a private limited company created on 2017-11-28 originating in United Kingdom. The business can be found at 101 New Cavendish Street, 1St Floor South, London W1W 6XH. Celex Oncology Innovations Limited operates Standard Industrial Classification: 21100 - "manufacture of basic pharmaceutical products".

Company details

Name Celex Oncology Innovations Limited
Number 11085607
Date of Incorporation: November 28, 2017
End of financial year: 31 December
Address: 101 New Cavendish Street, 1st Floor South, London, W1W 6XH
SIC code: 21100 - Manufacture of basic pharmaceutical products

Moving on to the 3 directors that can be found in this business, we can name: Carsten F. (in the company from 21 July 2019), Laurence C. (appointment date: 28 November 2017), Mustafa D. (appointed on 28 November 2017). The official register indexes 3 persons of significant control, namely: Mustafa D. owns over 1/2 to 3/4 of shares , over 1/2 to 3/4 of voting rights, Vasileios X. has substantial control or influence, Laurence C. owns 1/2 or less of shares, 1/2 or less of voting rights.

Directors

People with significant control

Mustafa D.
28 November 2017
Nature of control: 50,01-75% shares
50,01-75% voting rights
right to appoint and remove directors
Vasileios X.
25 September 2019 - 8 June 2020
Nature of control: significiant influence or control
Laurence C.
28 November 2017 - 25 September 2019
Nature of control: 25-50% voting rights
25-50% shares

Filings

Categories:
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
(CS01) Confirmation statement with updates 2023-12-04
filed on: 2nd, January 2024 | confirmation statement
Free Download (4 pages)